BeOne Medicines (ONC) Other Working Capital Changes (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Other Working Capital Changes of $6.2 million for Q1 2026, down 50.1% year-over-year from $12.4 million in Q1 2025, and up 174.34% quarter-over-quarter from -$8.3 million in Q4 2025.
BeOne Medicines (ONC) Other Working Capital Changes (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Other Working Capital Changes for 12 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 50.1% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at -$4.9 million (down 118.56% YoY), while the FY2025 annual figure was $1.3 million, down 88.42% from the prior year.
- Other Working Capital Changes rose to $6.2 million in Q1 2026 per ONC's latest filing, from -$8.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $75.1 million in Q2 2025 and bottomed at -$100.6 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$6.3 million across 5 years, with a median of -$13.0 million in 2023.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 740.04% — and 2025, when it sank 2251.84%.
- BeOne Medicines' Other Working Capital Changes stood at -$39.0 million in 2022, then jumped by 740.04% to $249.6 million in 2023, then plunged by 100.14% to -$353000.0 in 2024, then tumbled by 2251.84% to -$8.3 million in 2025, then surged by 174.34% to $6.2 million in 2026.
- Business Quant data shows ONC's Other Working Capital Changes at $6.2 million in Q1 2026, -$8.3 million in Q4 2025, and -$5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.38 Mn |
| Jun 30, 2026 | 11.38 Mn |
| Jun 30, 2026 | 11.38 Mn |
| Mar 31, 2026 | -15.27 Mn |
| Mar 31, 2026 | -15.27 Mn |
| Mar 31, 2026 | -15.27 Mn |
| Dec 31, 2025 | 18.08 Mn |
| Dec 31, 2025 | 18.08 Mn |
| Dec 31, 2025 | 18.08 Mn |
| Sep 30, 2025 | -100.56 Mn |
| Sep 30, 2025 | -100.56 Mn |
| Sep 30, 2025 | -100.56 Mn |
| Jun 30, 2025 | 75.05 Mn |
| Jun 30, 2025 | 75.05 Mn |
| Jun 30, 2025 | 75.05 Mn |
| Mar 31, 2025 | -29.74 Mn |
| Mar 31, 2025 | -29.74 Mn |
| Mar 31, 2025 | -29.74 Mn |
| Dec 31, 2024 | -35.62 Mn |
| Dec 31, 2024 | -35.62 Mn |